glutamic acid has been researched along with pyrimidinones in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Bristow, DR; Dupere, JR; Zamani, MR | 1 |
Dohovics, R; Hermann, A; Janáky, R; Oja, SS; Saransaari, P; Varga, V | 1 |
Almo, SC; Cahill, SM; Evans, GB; Fedorov, A; Furneaux, RH; Kicska, GA; Lewandowicz, A; Schramm, VL; Shi, W; Tyler, PC | 1 |
Gangjee, A; Kisliuk, RL; McGuire, JJ; Zeng, Y | 1 |
Cowan, A; Rawls, SM; Werkheiser, JL | 2 |
Jeong, HJ; Vaughan, CW; Wrigley, PJ | 1 |
Kwatra, D; Luo, S; Mitra, AK; Pal, D; Paturi, KD; Shah, SJ | 1 |
Eagen, KP; Ganem, B; Hess, GP; Lewis, RW; Mabry, J; Polisar, JG | 1 |
Li, M; Sobolevsky, AI; Yelshanskaya, MV | 1 |
Allan, RW; Drane, WE; Ivey, AM; Kaye, FJ; Mendenhall, WM | 1 |
Abedalthagafi, M; Barker, FG; Brastianos, PK; Cahill, DP; Curry, WT; Dunn, IF; Frederick, DT; Getz, G; Gill, CM; Jones, PS; Louis, DN; Nahed, BV; Nayyar, N; Panka, DJ; Romero, JM; Santagata, S; Shankar, GM; Sullivan, RJ; Taylor-Weiner, A | 1 |
Benedict, JJ; DeConti, R; Gibney, GT; Gonzalez, RJ; Kudchadkar, RR; McCardle, T; Messina, JL; Sloot, S; Smalley, KS; Sondak, VK; Turner, LM; Weber, JS; Zager, JS | 1 |
Brown, BM; Deng, L; Gustafson, A; Hackos, DH; Hanson, JE; Lupardus, PJ; Schwarz, JB; Sellers, BD; Volgraf, M; Wallweber, HJA; Wang, TM; Wong, E | 1 |
Adachi, Y; Bando, H; Ebi, H; Faber, AC; Kitai, H; Kotani, H; Tomida, S; Voon, DC; Yano, S; Yoshino, T | 1 |
Li, G; Shi, Z; Shou, Y; Wang, Q; Xia, P; Yan, S; Yin, J; Zhang, K | 1 |
Fedinec, AL; Harsono, M; Liu, J; Parfenova, H; Pourcyrous, M; Zhang, R | 1 |
17 other study(ies) available for glutamic acid and pyrimidinones
Article | Year |
---|---|
An immortalised murine hypothalamic neuronal cell, GT1-7, expresses functional histamine H1 receptors.
Topics: Animals; Carbachol; Cell Line, Transformed; Dose-Response Relationship, Drug; Glutamic Acid; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Hypothalamus; Inositol Phosphates; Kinetics; Mice; Neurons; Neuropeptide Y; Piperidines; Pyrimidinones; Ranitidine; Receptors, Histamine H1; Serotonin; Substance P; Tritium | 1994 |
Interference of S-nitrosoglutathione with the binding of ligands to ionotropic glutamate receptors in pig cerebral cortical synaptic membranes.
Topics: Alanine; Animals; Binding, Competitive; Cerebral Cortex; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Kainic Acid; Kinetics; Ligands; Neuroprotective Agents; Nitroso Compounds; Piperazines; Pyrimidinones; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; S-Nitrosoglutathione; Swine; Synaptic Membranes; Uracil | 2000 |
Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase.
Topics: Animals; Asparagine; Binding Sites; Catalysis; Cattle; Crystallography, X-Ray; Enzyme Inhibitors; Glutamic Acid; Hydrogen Bonding; Hydrogen-Ion Concentration; Hypoxanthine; Imines; Nuclear Magnetic Resonance, Biomolecular; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Ribonucleosides; Static Electricity; Substrate Specificity; Thermodynamics | 2002 |
Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Furans; Glutamic Acid; Humans; Peptide Synthases; Pyrimidines; Pyrimidinones; Pyrroles; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 2005 |
Icilin evokes a dose- and time-dependent increase in glutamate within the dorsal striatum of rats.
Topics: Animals; Ankyrins; Behavior, Animal; Calcium Channels; Corpus Striatum; Dose-Response Relationship, Drug; Ganglia, Spinal; Glutamic Acid; Male; Pyrimidinones; Rats; Rats, Sprague-Dawley; Time Factors; TRPA1 Cation Channel; TRPC Cation Channels; TRPM Cation Channels | 2006 |
Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum.
Topics: Analysis of Variance; Animals; Area Under Curve; Behavior, Animal; Corpus Striatum; Drug Interactions; Electrochemistry; Glutamic Acid; Male; Morphinans; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Shivering; Spiro Compounds | 2007 |
Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurones.
Topics: Afferent Pathways; Animals; Ankyrins; Calcium Channels; Cold Temperature; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Male; Menthol; Patch-Clamp Techniques; Posterior Horn Cells; Pyrimidinones; Rats; Rats, Sprague-Dawley; Synaptic Transmission; TRPA1 Cation Channel; TRPC Cation Channels; TRPM Cation Channels | 2009 |
Effect of HEPES buffer on the uptake and transport of P-glycoprotein substrates and large neutral amino acids.
Topics: Adenosine Triphosphate; Amino Acids, Neutral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cell Line; Cell Membrane Permeability; Cyclosporine; Dogs; Glutamic Acid; HEPES; Humans; Lopinavir; Phenylalanine; Pyrimidinones; Ritonavir; Verapamil | 2010 |
Dihydropyrimidinone positive modulation of delta-subunit-containing gamma-aminobutyric acid type A receptors, including an epilepsy-linked mutant variant.
Topics: Alanine; Allosteric Regulation; Cell Line; Drug Synergism; Epilepsy; Genetic Variation; Glutamic Acid; Humans; Mutagenesis, Site-Directed; Protein Binding; Protein Isoforms; Protein Subunits; Pyrimidines; Pyrimidinones; Receptors, GABA-A; Thiones | 2010 |
Structure of an agonist-bound ionotropic glutamate receptor.
Topics: Animals; Cross-Linking Reagents; Crystallography, X-Ray; Cysteine; Glutamic Acid; HEK293 Cells; Humans; Ion Channel Gating; Models, Chemical; Organophosphonates; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrimidinones; Quinoxalines; Rats; Receptors, AMPA | 2014 |
Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
Topics: Adult; Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Compassionate Use Trials; Glutamic Acid; Humans; Imidazoles; Lung Neoplasms; Male; Mandibular Neoplasms; Molecular Targeted Therapy; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Oximes; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Radiography; Treatment Outcome; Valine | 2015 |
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Craniopharyngioma; Craniotomy; Cytoreduction Surgical Procedures; Drug Administration Schedule; Glutamic Acid; Humans; Imidazoles; Magnetic Resonance Imaging; Male; Molecular Targeted Therapy; Mutation; Neoplasm Recurrence, Local; Neoplasm, Residual; Oximes; Pituitary Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Treatment Outcome; Valine | 2016 |
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Follow-Up Studies; Glutamic Acid; Humans; Imidazoles; Indoles; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Mutation, Missense; Neoadjuvant Therapy; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Retrospective Studies; Skin Neoplasms; Sulfonamides; Treatment Outcome; Valine; Vemurafenib | 2016 |
A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain.
Topics: Allosteric Regulation; Binding Sites; Calcium; Dose-Response Relationship, Drug; Doxycycline; Electric Stimulation; Excitatory Amino Acid Agents; Glutamic Acid; Glycine; HEK293 Cells; Humans; Membrane Potentials; Patch-Clamp Techniques; Protein Domains; Pyrimidinones; Receptors, N-Methyl-D-Aspartate; Sulfonamides; Synaptic Transmission; Transfection | 2017 |
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers.
Topics: Amino Acid Substitution; Animals; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Glutamic Acid; HT29 Cells; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Mutant Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tumor Cells, Cultured; Valine; Xenograft Model Antitumor Assays | 2018 |
Stack-Based Hydrogels with Mechanical Enhancement, High Stability, Self-Healing Property, and Thermoplasticity from Poly(l-glutamic acid) and Ureido-Pyrimidinone.
Topics: Glutamic Acid; Hydrogels; Polymers; Pyrimidinones; Tissue Engineering | 2020 |
The cold receptor TRPM8 activation leads to attenuation of endothelium-dependent cerebral vascular functions during head cooling.
Topics: Animals; Animals, Newborn; Arterioles; Body Temperature; Bradykinin; Brain; Cerebrovascular Circulation; Endothelium; Female; Glutamic Acid; Head; Hypercapnia; Hypothermia, Induced; Male; Nitroprusside; Pyrimidinones; Rewarming; Sodium Channel Agonists; Swine; TRPM Cation Channels; Vasodilation; Vasodilator Agents | 2021 |